Introduction
Hepatitis B virus (HBV) has a compact genome of 3.2 kb with four partially overlapping open reading frames (ORFs). The smallest is the X ORF (465 bases) which encodes the 154 amino acid X protein (Kay et al., 1985; Meyers et al., 1986; Koike et al., 1988) . Other members of the hepadnavirus family, isolated from woodchuck (WHV) and ground squirrel (GSHV) also possess an ORF encoding a polypeptide with similar size and function as the HBV X protein. The avian hepadnaviruses (duck and heron hepatitis B viruses), however, lack a homologous ORF (Rossner, 1992) .
Within the X ORF region are the repeat sequences DR1 and DR2, which are essential for genome replication involving an RNA intermediate (Ganem et al., 1994) . Additionally, the X region carries most of the core promoter region and an adjoining enhancer region (enhancer II) immediately upstream (Yuh et al., 1992; Okamoto et al., 1994) . Antibodies to the HBV X protein (which is also known as HBxAg) have been detected in the sera of HBV infected patients, and HBxAg has been found in the liver of infected individuals and in human hepatoma cells (Moriarty et al., 1985; Stemler et al., 1990) . The main location of this protein in the hepatocyte is not known with certainty.
The HBV X protein is a transcriptional transactivator. Transfection of human hepatoma cells with the HBV genome containing a frameshift mutation in the X ORF caused a lower than average accumulation of all viral mRNAs (Colgrove et aI., 1989; Koike et al., 1989) . The X protein not only enhances transcription from the HBV genome, but is capable of up-regulating transcription from a wide variety of cellular and viral promoters (reviewed by Rossner, 1992) . This function is mediated through protein-protein interaction involving cellular factors. The elevated expression of MHC class I antigens on the surface of hepatocytes during HBV infection may be the result of transcriptional transactivation by the X protein (Pignatelli et al., 1986; Zhou et al., 1990) .
One of the transactivating functions of the X protein has been suggested to be mediated through inhibition of hepatic serine protease activity, thereby protecting cellular transcription factors from degradation or processing . Indeed, the X protein appears to carry sequences corresponding to the Kunitz domain, which is a characteristic property of these inhibitors. In the X protein, however, the Kunitz domainlike region is split . In addition, the X protein has recently been found to have both (d)ATPase activity and nucleoside diphosphate kinase (NDPK) activity . Its gene was suggested to be derived from cellular genes coding for the NDPK group of enzymes .
A small proportion of chronic HBV carriers develop hepatocellular carcinoma (HCC) and integrated HBV DNA is often found in HCC tissues. HBV X protein has been implicated in the development of HCC in chronic carriers through its transactivating function (Rossner, 1992) . Hybrid virus-cell transcripts encoding truncated versions of the X protein have been detected in human and woodchuck liver tumours (Wei et al., 1995) . A recent study has shown that the X protein affects a wide range of functions of the tumour suppressor gene product p53, with the potential for neoplastic development (Wang et al., 1994) . It is known to bind directly to p53, thereby reducing the transcriptional activation potential of the latter (Truant et al., 1995) .
Recently, a large number of studies taking advantage of PCR and subsequent sequencing of amplified HBV DNA have been published. Mutations in the precore, core, pre-S and S genes have been found and their implications analysed, but there have been few reports of X gene variations (Lo et al., 1988; Rossner, 1992; Norder et al., 1994) . We report here sequence analysis of the X-gene from 29 HBsAg-positive patients, all but one of whom were chronic HBV carriers. The variations found are compared to others in the databank and the possible significance of conserved regions in the ORF and of specific base changes in the core promoter is considered. Additionally, phylogenetic analysis of the X gene was performed using two complementary approaches.
Methods
Serum samples. Twenty-eight of the 29 serum samples examined were from chronic HBsAg-carriers and were collected between 1990 and 1993. The remaining patient (no. 27) had acute self-limited hepatitis.
HBV markers were tested for with RIA tests from Abbott Laboratories. Twenty samples were HBeAg positive, five were antiHBe positive, three samples were HBeAg positive and anti-HBe positive simultaneously and one sample had neither HBeAg nor antiHBe (Table 1) .
PCR. DNA was extracted from serum by the phenol~hloroform method, and amplification of extracted DNA was performed as (Ljunggren & Kidd, 1991; Kidd-Ljunggren et aL, 1994) . Oligonucleotide primers KL21 and KL22 were used for all samples to amplify the X gene ( Fig. 1) . In some cases, three other PCR primer combinations were used in order to yield sufficient product for direct sequencing: KL21 with KL24, KL23 with KL6, or KL23 with KL22. Additionally, the pre-S/S region was amplified using primers KL12 and KLI4, for subsequent genetic subtyping of the HBV strains (see below). Standard precautions were taken to prevent carryover of DNA, and there was never any evidence of contamination in controls without sample DNA. The amplified DNA was run on 2 % agarose gels containing ethidium bromide and visualized under UV light.
DNA sequencing. The amplified DNA was sequenced directly by the method of Kretz et aL (1989) . Primers KL21, KL22, KL6, KL23 and KL24 were used for sequencing the X gene (Fig. 1) . Additionally, the HBV subtype of each strain was determined using sequencing primer KL19 and establishing the identity of S-gene codons 122 and 160. Codon 122 determines d/y reactivity and codon 160 w/r reactivity, respectively (Okamoto et al., 1987) .
Data analysis. Databank entries carrying HBV X gene sequences were obtained using the string search program FASTA (Genetics Computer Group Inc., Madison, Wis., USA). Alignments of up to 82 sequences for feature comparisons were performed using CLUSTAL (Higgins & Sharp, 1988) on Lasergene Megalign software (DNAStar Inc., Madison, Wis., USA). For ease of identity, all databank sequences were handled throughout using their databank accession numbers. The nucleotide numbering of Fujiyama et al. (1983) was used throughout.
Multiple sequence alignments for deriving tree topologies were performed by CLUSTALV (Higgins et aL, 1992) . For phylogeny based on the principle of maximum parsimony, the PHYLIP programs DNAPARS or PROTPARS were used (Felsenstein, 1989 (Felsenstein, , 1993 . For DNA phylogenies from distance matrices, the PHYLIP programs DNADIST and FITCH were used consecutively. Both approaches made use of output files from the general bootstrap program SEQBOOT (Felsenstein, 1993) , which in turn used CLUSTALV alignments as input files. For each bootstrap determination, the input order of the sequences was jumbled five times. The multiple tree files thus obtained from DNAPARS, PROTPARS or FITCH were used to obtain a majority rule consensus tree (program CONSENSE), and the tree was plotted using DRAWTREE (Felsenstein, 1993) .
Results and Discussion
The X genes from 28 chronic HBsAg carriers and one acute HBV case were characterized in this study. These patients were from 14 countries spanning Europe, Asia and the Pacific (Table 1 ). The genetic subtypes of the HBV strains, determined by sequencing codons 122 and 160 of the S gene (Okamoto et al., 1987) , were as follows: 10 strains were adw, 8 strains were adr, and 11 were of subtype ayw.
X gene and X protein sequence variation
All but one of the 29 X ORFs sequenced were 465 bases long. Patient 16 had an 8 base deletion from positions 1635-1642 inclusive, resulting in a frameshift and premature stop codon at base positions 1656 1658. Deletions in this region have been described before (Laskus et al., 1994; Uchida et al., 1994; Okamoto et al., 1994) .
The predicted X protein sequences of the 29 HBV strains under study were compared with 53 equivalent sequences available from the databank (data not shown). Our strains carried previously undescribed (or vary rare) amino acid variations at 19 codon positions (Table 2 ). Fig. 2 shows an alignment of the 29 X protein sequences against 32 selected databank sequences for which there was information on origin of the strain. Further criteria for selecting these sequences were (a) a normal start codon, and (b) a predicted X protein which was not fused to precore/core ORF products.
It was possible to differentiate one hypervariable region (from residues 26-52) and several conserved regions in the primary sequence of the X protein. The first conserved region of more than five residues (amino acid positions 13~5) corresponds to part of the overlap region of the P and X ORFs. The second and longest conserved region on the primary sequence (from residues 53-77) shows very few deviations from the consensus and corresponds to the end of the P ORF overlap region. Apart from the sequences of strains X69798, X75658 and X75663, which are close to each other phylogenetically (Norder et al., 1994) , region 89-115 is also relatively well conserved. Region 132-143 appears almost totally conserved, except in deletion variants with frameshifts and hence truncated X proteins, such as that of patient 16. Except for variability in residue 144, the conserved region from residue 132 normally continues to the C terminus of the protein, in which residues 147-154 correspond to the overlap between the X and precore/ core ORFs. One of the conserved regions above was implicated by as being important for interaction of the X protein with cellular proteins (residues 131-142) and encompasses regions found by Arii et al. (1992) and Kim et al. (1993) to be essential for its transactivating function. This region (consensus 
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forming the two parts of the proposed Kunitz domain . A' O' symbol above the consensus X protein sequence refers to the proposed amino acid similarity with nucleoside diphosphate kinases Wei et al. (1995) found that the junctions of transcripts carrying both X gene and cellular sequences in hepatocellular carcinoma tissue preserved this amino acid sequence. The above conserved region spanning amino acid residues 131-140 represents the C-terminal part of the serine protease inhibitor Kunitz domain-like sequence described by S. Takada and K. Koike (see (Fig. 2) . The N-terminal part of the Kunitz domain-like sequence (residues 56-72) is distant from the C-terminal part by some 50 amino acids, but both of these relatively hydrophobic regions appear to be essential for transactivation (Arii et al., 1992; . The N-terminal part of this proposed domain (consensus sequence 56RGLP-VCAFSSAGPCALR 7~) was very well conserved in our 29 strains and also in databank sequences (Fig. 2) . Patient 15 was a notable exception, having a strain with proline at position 58, which might be expected to change the local conformation of the protein. The cysteine residues at positions 69 and 137, proposed by to form a disulphide bridge, were conserved in 80 predicted X proteins (data not shown).
Thus, both parts of the proposed Kunitz domain were well conserved in all HBV genes examined in the study. This gives further support for the importance of these regions for transactivation (Arii et al., 1992; Kim et al., 1993; Nakatake et al., 1993; , although overlap of the X ORF encoding the N-terminal part of this domain with the P ORF may be an additional reason for amino acid conservation in this region. There is evidence from mutational analysis of in-frame ATG codons within the X ORF (positions 79 and 103) that there may more than one X product, initiated from internal start sites, and that the domains most important for the stimulatory activity of the protein lie in the Cterminal half of the molecule (Nakatake et al., 1993) . A similar study by Kwee et al. (1992) suggested that the three possible translation products of the X region may have transcriptional regulatory activities, and that the Nterminal half of the fulMength 17 kDa protein may be required to activate some promoters.
The X protein gene has been proposed to be a derivative of nucleoside diphosphate kinase genes (DeMedina & Shaul, 1994) (Fig. 2) . The latter group of enzymes are hexameric (Dumas et al., 1992) , but the monomers can have a similar length to that of the X protein, and the sequences are somewhat similar (DeMedina & Shaul, 1994) . However, the C-terminal part of the Kunitz domain-like region of the X protein, characteristic of serine protease inhibitors, does not feature in the primary sequences of different nucleoside diphosphate kinases. Whether recombination or convergent evolution, or some other explanation can be used to reconcile these two suggestions as to the origin of the X gene and characteristics of the protein, should be addressed. Both suggestions have been supported by experiment . That the two parts of the proposed Kunitz domain are separated from each other by some 50 amino acids in the X protein also requires explanation.
Phylogenetic analysis
The 29 X gene sequences characterized in this study were used to generate an unrooted phylogenetic tree by the method of maximum DNA parsimony. Combined with the bootstrap method for evaluating the likelihood of branch nodes (see Brown, 1994) , this method provided a consensus tree with four main branches (Fig. 3a) . An equivalent analysis of the predicted protein sequences yielded a similar tree (Fig. 3 b) . With minor differences in outer branch positions, the trees derived from both DNA and protein sequences had the same four clusters of sequences.
In an attempt to define the four clusters shown by the 29 strains, their X gene sequences were compared to the X genes in 33 databank sequences for which there was information on the geographical origin of the strain. These gene sequences correspond to the translated sequences shown in Fig. 2 , except that an additional strain with a mutated start codon (accession no. M57663) was included in the phylogenetic analysis. The 62 sequences clustered into four main groups, corresponding to the genetic subgroups A to D of Okamoto et al. (1988) (Fig. 4) .
The X genes of strains proposed by Norder et al. (1992) to belong to subgroup E (X75657 and X75664) and F (X69798, X75658 and X75663) clustered with subgroups D and B, respectively. As the DNA parsimony program DNAPARS finds node positions but does not take serious account of branch lengths (J. Felsenstein, personal communication), an alternative approach based on distance matrix analysis, which does estimate distances, was used (programs DNADIST and FITCH). The resulting tree showed a marked genetic distance (by branch length) between the X genes of subgroup F strains and those of other strains, including subgroup B X75663) are even obvious when comparing alignments by eye (see Fig. 2 ). Even so, tree building using DNA parsimony and distance matrix methods indicated that these X gene sequences probably branched from the same ancestral genes as subgroup B strains.
The origins of the various strains depicted in Fig. 4 were compared. The majority of subgroup A strains came from northern Europe, the United States or the Philippines. Most of the subgroup D strains came from southern Europe, Africa, the Middle East and India. The majority of subgroup B and C strains came from the Far East and the Pacific. The three strains designated subgroup F came from Brazil, Colombia and France. The common branching pattern from the centre of Figs  3 (a, b) and 4 to give four main clusters of sequences implies that the ancestral X genes of subgroup A and D strains may have been marginally more related to each other than to the ancestral X genes of the others; and similarly for the subgroup B and C strains. It thus appears possible to differentiate the phylogeny of most Western Hemisphere strains from that of most Eastern Hemisphere strains. Norder et al. (1994) suggested that HBV strains of subgroup F may represent the original strains of the New World. This possibility must be regarded as such with so few representative strains, not least because one of the three strains came from France. However, the main tree dichotomy between Western Hemisphere and Eastern Hemisphere X genes (Figs 3 a, b and 4) suggests that the ancestral X genes of subgroup F branched from the ancestry of subgroup B strains, probably in the Eastern Hemisphere.
The existence of X gene subgroups A and D might be explained by geographical separation, as the majority of A strains are detected in northern Europe, the United States (which has historical affiliations with northern Europe), and the Philippines (which has historical associations with the United States). Divergence of the other two main X gene subgroups, B and C, both mapping to the Far East and Pacific regions, is less easy to explain on geographical or anthropological grounds. One possibility is that geographical separation between subgroups B and C once existed but exists no longer. Another possibility is that divergence of HBV strains in the Far East involved another factor such as population susceptibility, for example through HLA type or some other genetic characteristic of the host.
There is some evidence for an influence of HBV subtype in Japan (adr vs adw) on time of conversion from HBeAg positive to anti-HBe positive status (Shiina et al., 1991a, b) . These subtypes in Japan correspond to subgroups C and B, respectively, such that patients infected with subgroup B strains appeared to seroconvert earlier. Whatever the mechanism which caused the co- of the strain was given. The DNA sequence of Brazilian strain w4B (accession no. X69798; Naumann et al., 1993) was chosen arbitrarily as the outgroup, and 500 bootstrap operations were done. A to D refers to subgroup designation (Okamoto et al., 1988) . confined to parts or positions of the ORF which have not been described to be important for transactivation, and which often involve variations in all strains, and not just subgroup B or subgroup C strains. A comparison of X protein sequences in terms of subgroup-specific amino acid changes revealed that subgroups A, B, C and F have at least one amino acid position where the identity of the residue is strictly maintained and unique for that subgroup (Table 3) . Subgroup D has no such subgroup-specific identity.
existence of HBV subgroup B and C strains in the one large area, it seems clear by analysis of the X gene variations that the latter probably show the effect rather than being the cause of subgroup divergence. Thus, X gene and X protein variation at the subgroup level is
Variations in regulatory sequences
The DNA sequences of our 29 strains were examined for variations in regulatory sequences within the region spanning the X ORF. Regulatory sequence DR1 (TTCACCTCTGC; nucleotide positions 1696-1706) and ...... [-~, D,[-D,[.-[-[,-E-,D,D,D, ......... ~ ~ o ...... ['-[-D,[-[-['-[~ ~ [-,D,~, ['-......... [-.,[.- its repeat DR2 (positions 1462-1472) were totally conserved in all strains, but for the fact that the HBV strain from patient 9 had a C to A substitution at position 1464. The HBV core promoter is a very important control region in that it not only directs transcription of the precore/core sequences which lead to production of HBeAg, but its functioning has a direct role in the formation of pregenomic RNA (Siddiqui, 1991) . The main part of the promoter lies within the 3' end of the X ORF and spans the 70 nucleotides immediately upstream of the AUG start codon for precore translation (positions 1616-1685) (Yuh et al., 1992; Okamoto et al., 1994) . Our 29 study strains showed considerable variability in this region (Fig. 5) . The most obvious difference was the eight nucleotide deletion in the strain infecting patient 16, similar to a deletion in a strain from a symptom-free HBV carrier (accession no. D23677) described by Horikita et al. (1994) , and to at least one other strain described by Okamoto et al. (1994) . These authors described several point mutations within the core promoter which were also seen in the present study.
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A survey on 57 carriers with anti-HBe ) revealed a high number of patients with mutations at or around the region of the promoter which is thought to be the RNA polymerase binding site (Corden et al., 1980 (Corden et al., ) (positions 1630 (Corden et al., -1636 . The transcription initiation site itself, some 25 positions downstream, was highly conserved. In 40 of 49 carriers with core promoter mutants, an A to T change at position 1634 and/or a G to A change at position 1636 were detected. The core promoter mutated in two chronic carriers as they seroconverted from HBeAg positive to anti-HBe positive, without any simultaneous mutations in the precore gene (codon 28) being detected. These authors suggested that changes in the core promoter alone would be able to give an HBeAg negative phenotype through regulation of transcription.
Thus, AGG is the 'consensus' sequence supposedly associated with HBeAg expression, whereas variations at nucleotide positions 1634 and 1636 are suggested to hamper HBeAg production. Eighteen of 19 samples with sequence AGG in this study were HBeAg positive (Table  4 and In addition to the above, six previously undescribed or very rare mutations in the core promoter were seen in this study, together with ten mutations (at nine positions) represented in the databank by one or, at most, two strains (Fig. 5 ). There were otherwise several well conserved regions within the core promoter. Except for the strain carrying a deletion, the initiation sites for precore mRNAs (between nucleotides 1654 and 1668, 32 to 18 positions upstream of the precore start codon; Okamoto et al., 1994) were fully conserved in all cases.
Cases of so-called hepatitis F (without conventional hepatitis virus markers) have been attributed to HBV mutants with deletions in the core promoter region (Uchida et al., 1994) . Horikita et al. (1994) found similar strains in a small number of anti-HBe positive patients, and presented some evidence that an increase in severity of disease may be accompanied by a shift within the patient from circulating strains with deletions within the core promoter to strains without. Hasegawa et al. (1994) described a fulminant HBV strain without any deletion in the putative core promoter but with a precore stop at codon 28 which directed a much higher level of coreassociated antigens in transfected cells than other strains with a precore stop. These authors suggested that mutations other than those in the precore gene may have been responsible for the variant behaviour of this strain. We have noted that the core promoter of this strain carried TGA at nucleotide positions 1634-1636. On the supposition that such mutations would down-regulate precore mRNA levels (as suggested by Okamoto et al., 1994), the results of these authors suggest that the apparent aggressiveness of an HBV strain in an anti-HBe positive patient may be due to factors other than these core promoter changes.
Conclusions
This study attempted to investigate the extent of variability within the X gene region of HBV. By contributing 29 X gene sequences from 14 countries and comparing those with equivalent sequences from the databank, a map of sequence variability-has been achieved for both the predicted X protein, and the core promoter region within the X gene. Various regions of the X protein have been implicated as being important for its transactivating functions, negative regulatory function, antigenicity, NDPK activity and serine protease inhibitor activity. Experimental work on these functions may have been confounded in some studies if there are indeed not just one, but three protein products based on differential translation from internal start codons. It is clear from the present study, simply by comparison of as many sequences as possible, that the region encompassing the second part of the Kunitz domain is a strong contender as a functional region of the protein, based on amino acid conservation.
Variation of the X gene sequences and predicted protein sequences studied in terms of phylogeny has yielded results which imply that there are four main genotypes of HBV, as originally proposed by Okamoto et al. (1988) . Subgroup E does not exist in terms of X gene identity, and subgroup F strain X genes show a distant, but distinct relationship to the X genes of subgroup B.
Based on the work of Okamoto et al. (1994), core promoter analysis has shown that there was a distinct relationship in this study between HBe/anti-HBe status and the identity of just two nucleotides. It is impossible to make conclusions from this work on whether such base changes are the direct cause or effect of a change in HBeAg marker status, but clearly this is another variable which may have a bearing on the various outcomes of infection with HBV. Certainly, our results suggest that there is a strong need for a follow-up study of HBeAg positive patients until or beyond seroconversion, analysing both core promoter identity and precore sequence.
